NEW PROCESS FOR THE SYNTHESIS OF IMIDAZO[4,5-B]PYRIDINE DERIVATIVES AS POTENT ORALLY-ACTIVE THROMBOXANE-A2 RECEPTOR ANTAGONISTS

被引:10
|
作者
NICOLAI, E
CLAUDE, S
TEULON, JM
机构
[1] Carpibem, Rueil Malmaison, 92500
关键词
D O I
10.1002/jhet.5570310113
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A new synthetic route to prepare the 4-[3-(4-chlorophenyl)methyl-6-chloroimidazo[4,5-b]pyridin-2-yl]-3,3-dimethylbutanoic acid (UP 116-77) is described. UP 116-77 is a potent orally active TXA2/PGH2 receptor antagonist currently under pharmacological investigation. Its development needed a suitable synthesis for industrial processing. The cyclization of 3-amino-5-chloro-2-(4-chlorophenyl)methylaminopyridine 4 with 3,3-dimethylglutaric anhydride in refluxing acetic acid affords a new efficient and simple way to UP 116-77 and subsequently to various 2-substituted imidazo[4,5-b]pyridine derivatives.
引用
收藏
页码:73 / 75
页数:3
相关论文
共 50 条
  • [21] O-PHENYLPHENOLS - POTENT AND ORALLY-ACTIVE LEUKOTRIENE B-4 RECEPTOR ANTAGONISTS
    SOFIA, MJ
    FLOREANCIG, P
    BACH, NJ
    BAKER, SR
    COCKERHAM, SL
    FLEISCH, JH
    FROELICH, LL
    JACKSON, WT
    MARDER, P
    ROMAN, CR
    SAUSSY, DL
    SPAETHE, SM
    STENGEL, PW
    SILBAUGH, SA
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (24) : 3978 - 3981
  • [22] New and efficient synthesis of imidazo[4,5-b]pyridine-5-ones
    Zaki, MEA
    Proença, MF
    Booth, BL
    SYNLETT, 2005, (16) : 2429 - 2432
  • [23] Novel iminocoumarin imidazo[4,5-b]pyridine derivatives: design, synthesis, and biological evaluation
    Pavlinac, Ida Bocek
    Starcevic, Kristina
    Persoons, Leentje
    Banjanac, Mihailo
    Radovanovic, Vedrana
    Daelemans, Dirk
    Hranjec, Marijana
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2024, 60 (1-2) : 75 - 82
  • [24] Novel iminocoumarin imidazo[4,5-b]pyridine derivatives: design, synthesis, and biological evaluation
    Ida Boček Pavlinac
    Kristina Starčević
    Leentje Persoons
    Mihailo Banjanac
    Vedrana Radovanović
    Dirk Daelemans
    Marijana Hranjec
    Chemistry of Heterocyclic Compounds, 2024, 60 : 75 - 82
  • [25] ENANTIOSELECTIVE SYNTHESIS OF S-1452, AN ORALLY ACTIVE POTENT THROMBOXANE-A2 RECEPTOR ANTAGONIST
    OHTANI, M
    MATSUURA, T
    WATANABE, F
    NARISADA, M
    JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (06): : 2122 - 2127
  • [26] Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitors
    Baladi, Tom
    Aziz, Jessy
    Dufour, Florent
    Abet, Valentina
    Stoven, Veronique
    Radvanyi, Francois
    Poyer, Florent
    Wu, Ting-Di
    Guerquin-Kern, Jean-Luc
    Bernard-Pierrot, Isabelle
    Garrido, Sergio Marco
    Piguel, Sandrine
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (20) : 5510 - 5530
  • [27] THROMBOXANE-A2 RECEPTOR ANTAGONISTS - SYNTHESIS AND ACTIVITIES OF PHENYLSULFONAMIDO DERIVATIVES
    MAIS, DE
    MOHAMADI, F
    DUBE, GP
    KURTZ, WL
    BRUNE, KA
    UTTERBACK, BG
    SPEES, MM
    JAKUBOWSKI, JA
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1991, 26 (08) : 821 - 827
  • [28] AZULENE DERIVATIVES - NEW NONPROSTANOID THROMBOXANE-A2 RECEPTOR ANTAGONISTS
    TOMIYAMA, T
    WAKABAYASHI, S
    KOSAKAI, K
    YOKOTA, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) : 2323 - 2326
  • [29] MIGRATION OF N-SUBSTITUENT IN THE SERIES OF IMIDAZO[4,5-B]PYRIDINE AND IMIDAZO-[4,5-C]PYRIDINE DERIVATIVES
    YUTILOV, YM
    MIKHAILOVA, LE
    IGNATENKO, AG
    ZHURNAL ORGANICHESKOI KHIMII, 1986, 22 (02): : 445 - 446
  • [30] SYNTHESIS AND SAR STUDIES OF NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES AS POTENT, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    NICOLAI, E
    CURE, G
    GOYARD, J
    KIRCHNER, M
    TEULON, JM
    VERSIGNY, A
    CAZES, M
    CAUSSADE, F
    VIRONEODDOS, A
    CLOAREC, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (15) : 2371 - 2386